Area of research
Oncology · Immunology
Research interest
Research interests include CAR-T cell therapy research, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, and Immunotherapy and Immune Responses.
Ablation of prostaglandin E2 signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours
Gut Microbiota Modulation through <i>Akkermansia</i> spp <i>.</i> Supplementation Increases CAR T-cell Potency
Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion
Neuroinflammation detected by TSPO-PET precedes dopaminergic neuronal loss in mnt following BCMA-directed CAR-T therapy: Longitudinal multimodal neuroimaging and biomarker insights
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia
Programmable multispecific DNA-origami-based T-cell engagers
T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer
Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours
P06.07 CXCR6 expression enhances accumulation of anti-mesothelin CAR T cells at the tumor site and their therapeutic efficacy in pancreatic cancer xenografts